本发明公开了一种厄贝沙坦氢氯噻嗪胶囊及其制备方法，属于医药技术领域。
The invention discloses an irbesartan hydrochlorothiazide capsule and a preparation method thereof, belonging to the technical field of medicines.
结论综合考虑，厄贝沙坦片与氢氯噻嗪片联合应用是治疗单纯性收缩期高血压的最佳方案。
CONCLUSION Taking everything into consideration, Irbesartan combined with Hydrochlorothiazide was the best scheme in the treatment of the pure systolic hypertension.
目的比较厄贝沙坦与硝苯地平缓释片或氢氯噻嗪片联合治疗单纯性收缩期高血压的经济效果。
OBJECTIVE to compare the cost-effectiveness between Irbesartan combined with Extended Release Nifedipine or Hydrochlorothiazide in the treatment of the Pure Systolic Hypertension.
结论厄贝沙坦联合氢氯噻嗪降压以及逆转左心室肥厚的临床效果比单用厄贝沙坦更好。
Conclusion Irbesartan combined with hydrochlorothiazide effect on lowering the blood pressure and reversing of left ventricular hypertrophy is better than the single-use.
结论厄贝沙坦联合氢氯噻嗪疗效好，是治疗重度高血压安全有效的方法之一。
Conclusion The combination of Irbesartan plus DihydroChlorothiazide has definite benefit in patients with severe hyperpiesia.
结论厄贝沙坦联合氢氯噻嗪疗效好，是治疗重度高血压安全有效的方法之一。
Conclusion The combination of Irbesartan plus DihydroChlorothiazide has definite benefit in patients with severe hyperpiesia.
应用推荐